1. Gender

The male-to-female ratio is 1.1:1 to 1.4:1.

2. Age

According to Surveillance, Epidemiology, and End Results (SEER) program and Medical Research Council (MRC) data, the median age of patients with CML is 66 years. However, most patients who are admitted to medical therapy studies are 50 to 60 years old (median: approximately 53 years). Patients in bone marrow transplantation (BMT) studies are usually younger (median age: approximately 40 years).